Delivery Order SPE2DB20D2104-SPE2DB25FMXNW
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,627.40 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation leverages AmerisourceBergen's position as a major pharmaceutical distributor supporting federal medical procurement. The work will be performed at the company's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $9,288.90 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 5, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The place of performance is the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $46,648.39 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with a completion date of June 17, 2025, and represents a non-set-aside award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $73,229.67 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract fulfilling federal pharmaceutical procurement requirements. The award was placed to AmerisourceBergen's Corporate Office located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $31,905.60 on August 1, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.21 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements. The contract is performed at the vendor's corporate office location in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitive award carries a ceiling value of $66,334.24 under a firm fixed-price contract type with an ultimate completion date of September 9, 2025. The award was not designated as a set-aside contract, reflecting open competition among qualified vendors. AmerisourceBergen,...
- The Defense Logistics Agency awarded a $74,049.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 15, 2025. This competitive award, issued on September 12, 2025, carries no set-aside designation and represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,437.80 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count unit of use packages). This firm fixed-price delivery order, issued on July 21, 2025, represents a competitively awarded contract with an ultimate completion date of July 22, 2025, and carries no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units, valued at $17,229.27. This firm fixed price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the contract falls under the...